Correlagen is a leading developer of genetic testing that helps physicians to
diagnose disease earlier and more precisely for more tailored treatment.
Founded by researchers from Harvard and Children’s Hospital Boston, Correlagen
provides high-quality testing through the use of automated systems and
sophisticated result interpretation and reporting. Correlagen’s customers
range from private practitioners to researchers at some of the world’s foremost
academic institutions.
NEW: FOUR CARDIAC GENE SEQUENCES ADDED JULY 1, 2009
LMNA Gene Sequencing Expands Panel, Increases Sensitivity for Dilated
Cardiomyopathy Testing.
DCM-related heart failure is one of the most common
indications for heart transplantation, and DCM is also associated
with cardiac arrhythmias that can lead to stroke or sudden cardiac
death. LMNA gene defects have been identified in 5-10% of patients
with familial DCM.
Learn more...
TMEM43 Gene Sequencing Expands Panel for Arrythmogenic Right Ventricular
Dysplasia/Cardiomyopathy.
ARVD/C is the second most common cause of
sudden cardiac death in young adults and athletes, after hypertrophic
cardiomyopathy. TMEM43 defects cause a particularly severe form of
ARVD/C. Genetic testing can help to identify at-risk family members
before symptoms appear.
Learn more...
TGFBR1 and TGFBR2 Now Available for Diagnosis of Loeys-Dietz Syndrome
and Differential Diagnosis for Marfan Syndrome.
Loeys-Dietz syndrome (LDS) is a systemic connective tissue disorder
with cardiovascular and other manifestations that overlap with Marfan Syndrome
and/or vascular Ehlers-Danlos Syndrome. LDS is caused by mutuations in the
genes TGFBR1 (25%) or TGFBR2 (75%).
Learn more...
ALSO NOW AVAILABLE: EASIER ORDERING AND REPORTING FEATURES AND SERVICES
Our new requisitions significantly shorten
the time it takes to place an order.
Click on a link below to access our
new forms (see Ordering U.S. under each condition):
Our new report formats are now shorter, and more concise-with critical
decision-making information easy to review on a single page. In addition, our
new reports are available for sending electronically through a high-security
email platform giving you access to patient reports whether you are in or out
of the office setting. PDF formatted reports contain hyperlinks to a variety
of research, clinical and education resources. If you would like to test
drive our new electronic reports, please email us at
clientservices@correlagen.com.
|
